Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
  • Curriculum.
  • Publikationen.
  • Präsentationen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Archelos-Garcia Juan-Jose |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2022

Originalarbeit (Zeitschrift)

** Weiss, B; Pichler, A; Damulina, A; Buchmann, A; Hochmeister, S; Seifert-Held, T; Enzinger, C; Archelos, JJ; Khalil, M Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing.
Biomedicines. 2022; 10(9): Doi: 10.3390/biomedicines10092202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Weiss, B; Pichler, A; Damulina, A; Seifert-Held, T; Enzinger, C; Archelos-Garcia, J; Khalil, M Cerebrospinal fluid kappa free light chains in patients with an isolated band in isoelectric focusing
EUR J NEUROL. 2022; 29: 301-301. [Poster]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Voortman, MM; Damulina, A; Pirpamer, L; Pinter, D; Pichler, A; Enzinger, C; Ropele, S; Bachmaier, G; Archelos, JJ; Marsche, G; Khalil, M Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Biomolecules. 2021; 11(9): Doi: 10.3390/biom11091264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Abstract (Zeitschrift)

** Voortman, M; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos-Garcia, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early Multiple Sclerosis (MS)
EUR J NEUROL. 2018; 25: 434-434.-4th Congress of the European-Academy-of-Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Oral Communication]
Web of Science

 

2017

Originalarbeit (Zeitschrift)

** Kaiser, R; Archelos-Garcia, JJ; Jilg, W; Rauer, S; Sturzenegger, M Early Summer- Meningo Encephalitis (FSME) Tick Bone Encephalitis
AKTUEL NEUROL. 2017; 44(3): 161-169. Doi: 10.1055/s-0043-101424
Web of Science FullText FullText_MUG

 

** Pichler, A; Sellner, J; Harutyunyan, G; Sonnleitner, A; Klobassa, DS; Archelos-Garcia, JJ; Rock, H; Gattringer, T; Fazekas, F Magnetic resonance imaging and clinical findings in adults with tick-borne encephalitis.
J Neurol Sci. 2017; 375(2):266-269 Doi: 10.1016/j.jns.2017.02.003
Web of Science PubMed FullText FullText_MUG

 

** Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317727294-2055217317727294 Doi: 10.1177/2055217317727294 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Mult Scler. 2017; 23(11):1496-1505 Doi: 10.1177/1352458516681503 [Oral Communication]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Abstract (Konferenzband)

** Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

2016

Originalarbeit (Zeitschrift)

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Pichler, A; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Mult Scler. 2016; 22(12):1560-1568 Doi: 10.1177/1352458515624560
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
Web of Science

 

2015

Abstract (Zeitschrift)

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

** Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

** Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Mult Scler. 2014; 20(12):1569-1577 Doi: 10.1177/1352458514530020
Web of Science PubMed FullText FullText_MUG

 

** Wutte, N; Archelos, J; Crowe, BA; Zenz, W; Daghofer, E; Fazekas, F; Aberer, E Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
J Neurol Sci. 2014; 347(1-2):96-103 Doi: 10.1016/j.jns.2014.09.027
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Trentini, A; Vane, ML; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Koel-Simmelink, MJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Mult Scler. 2013; 19(4):436-442 Doi: 10.1177/1352458512458010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Patz, S; Trattnig, C; Grünbacher, G; Ebner, B; Gülly, C; Novak, A; Rinner, B; Leitinger, G; Absenger, M; Tomescu, OA; Thallinger, GG; Fasching, U; Wissa, S; Archelos-Garcia, J; Schäfer, U More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins.
J Neurotrauma. 2013; 30(14):1232-1242 Doi: 10.1089/neu.2012.2596
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545. [Poster]
Web of Science

 

** Patz, S; Trattnig, C; Grunbacher, G; Gully, C; Leitinger, G; Absenger, M; Tomescu, OA; Fasching, U; Archelos-Garcia, J; Schafer, U miR-451 REGULATES THE INDUCTION OF EARLY NEUROGENIC PROCESSES, PARTICULARLY, CELL POLARITY AND MIGRATION DURING THE ACUTE PHASE OF TBI
SHOCK. . 2013; 40: 26-26.-5th Congress of the European-Shock-Society (ESS); SEP 12-14, 2013; Vienna, AUSTRIA. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Raju, R; Devi, SK; Mehervani, C; Kumar, AS; Meena, AK; Reddy, PP; Pranay, P; Jain, S; Archelos-Gracia, JJ; Suneetha, S; Suneetha, LM Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.
Neurochem Res. 2011; 36(5):766-773 Doi: 10.1007/s11064-010-0397-7
Web of Science PubMed FullText FullText_MUG

 

2007

Übersichtsarbeit

** Archelos, JJ Treatment options in painful diabetic polyneuropathy
Wien Klin Wochenschr. 2007; 119(7-8):205-216 Doi: 10.1007/s00508-007-0795-2
Web of Science PubMed FullText FullText_MUG

 

2006

Kurzbericht/Letter

** Neuhaus, O; Manda, VS; Scarpatetti, M; Höfler, G; Hartung, HP; Archelos, JJ New diagnostic options in tuberculous meningitis?
Int J Tuberc Lung Dis. 2006; 10(8):944-944
Web of Science PubMed Google Scholar

 

Übersichtsarbeit

** Archelos, JJ; Fazekas, F IVIG therapy in neurological disorders of childhood.
J Neurol. 2006; 253 Suppl 5(11):V80-V86 Doi: 10.1007/s00415-006-5014-y
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Neuhaus, O; Manda, VS; Stuve, O; Archelos, JJ; Hartung, H Mechanisms of statins in multiple sclerosis - Preferential inhibition of activated T lymphocytes by an at least triple mode of action
NEUROLOGY. 2006; 66(5):A176-A176.-American Academy of Neurology 58th Annual Meeting; APR 1-8, 2006; San Diego (CA), USA. [Oral Communication]
Web of Science

 

2005

Originalarbeit (Zeitschrift)

** Neuhaus, O; Stüve, O; Archelos, JJ; Hartung, HP Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
J NEUROL SCI 2005 233: 173-177. Doi: 10.1016/j.jns.2005.03.030
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Neuhaus, O; Wiendl, H; Kieseier, BC; Archelos, JJ; Hemmer, B; Stüve, O; Hartung, HP Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
J Neuroimmunol. 2005; 168(1-2):128-137 Doi: 10.1016/j.jneuroim.2005.01.024
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Plaisier, E; Mougenot, B; Verpont, MC; Jouanneau, C; Archelos, JJ; Martini, R; Kerjaschki, D; Ronco, P Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
J Am Soc Nephrol. 2005; 16(11):3350-3356 Doi: 10.1681/ASN.2005050509 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Neuhaus, O; Manda, V; Scarpatetti, M; Hoefler, G; Hartung, H; Archelos, J Tuberculous meningitis - new diagnostic options?
J NEUROL 2005 252: 34-34.
Web of Science

 

** Neuhaus, O; Mando, VS; Stuve, O; Archelos, JJ; Hartung, HP Mechanisms of statins in multiple sclerosis - inhibition of activated T lymphocytes by dual action: impaired isoprenylation of guanosinetriphosphate-binding proteins and disruption of lipid microdomains
MULT SCLER 2005 11: S166-S166.
Web of Science

 

** Plaisier, E; Mougenot, B; Verpont, MC; Jouanneau, C; Archelos, J; Martini, R; Kerjaschki, D; Ronco, P Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells
NEPHROL DIALYSIS TRANSPLANT 2005 20: V211-V211.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Bartosik-Psujek, H; Archelos, JJ Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
J Neurol. 2004; 251(4):414-420 Doi: 10.1007/s00415-004-0336-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kieseier, BC; Archelos, JJ; Hartung, HP Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
Arch Neurol. 2004; 61(6):929-932 Doi: 10.1001/archneur.61.6.929 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Neuhaus, O; Stuve, O; Archelos, JJ; Hartung, HP Putative mechanisms of statins in multiple sclerosis - preferential inhibition of activated T lymphocytes
J NEUROIMMUNOL 2004 154: 226-226.
Web of Science

 

2003

Originalarbeit (Zeitschrift)

** Neuhaus, O; Wiendl, H; Kieseier, BC; Archelos, JJ; Hartung, HP Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators
NERVENARZT. 2003; 74(8): 704-707. Doi: 10.1007/s00115-003-1562-x
Web of Science PubMed FullText FullText_MUG

 

** Niederwieser, G; Buchinger, W; Bonelli, RM; Berghold, A; Reisecker, F; Költringer, P; Archelos, JJ Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
J Neurol. 2003; 250(6):672-675 Doi: 10.1007/s00415-003-1053-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Suneetha, LM; Singh, SS; Vani, M; Vardhini, D; Scollard, D; Archelos, JJ; Srinivasulu, M; Suneetha, S Mycobacterium leprae binds to a major human peripheral nerve glycoprotein myelin P zero (P0).
Neurochem Res. 2003; 28(9):1393-1399 Doi: 10.1023%2FA%3A1024904717612
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Neuhaus, O; Kieseier, BC; Archelos, JJ; Hartung, HP Response to Mousavizadeh et al.: Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis
TRENDS PHARMACOL SCI 2003 24: 564-565. Doi: 10.1016%2Fj.tips.2003.09.005
Web of Science FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Neuhaus, O; Archelos, JJ; Hartung, HP Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.
Trends Pharmacol Sci. 2003; 24(3):131-138 Doi: 10.1016%2FS0165-6147%2803%2900028-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Editorial

** Neuhaus, O; Archelos, JJ; Hartung, HP Statins in multiple sclerosis: a new therapeutic option?
Mult Scler. 2003; 9(5):429-430 Doi: 10.1191%2F1352458503ms952ed [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Originalarbeit (Zeitschrift)

** Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Kieseier, BC; Niederwieser, G; Hartung, HP; Archelos, JJ Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neurology. 2002; 59(7):990-997 Doi: 10.1212/WNL.59.7.990
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Hemmer, B; Archelos, JJ; Hartung, HP New concepts in the immunopathogenesis of multiple sclerosis.
Nat Rev Neurosci. 2002; 3(4):291-301 Doi: 10.1038/nrn784
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Krametter, DF; Stuenzner, D; Gruber-Sedlmayr, U; Weishaupt, A; Hartung, HP; Archelos, JJ Epitope-specific humoral immune response to myelin protein zero (PO) in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
NEUROLOGY 2002 58: A230-A231.
Web of Science

 

** Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Hartung, HP; Archelos, JJ Multiple sclerosis: Immunologic effects of statins in vitro: A new therapeutic approach?
NEUROLOGY 2002 58: A73-A73.
Web of Science

 

2001

Originalarbeit (Zeitschrift)

** Krametter, D; Niederwieser, G; Berghold, A; Birnbaum, G; Strasser-Fuchs, S; Hartung, HP; Archelos, JJ Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Mult Scler. 2001; 7(1):13-18 Doi: 10.1191%2F135245801676514804
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Yan, WX; Archelos, JJ; Hartung, HP; Pollard, JD P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.
Ann Neurol. 2001; 50(3):286-292 Doi: 10.1002%2Fana.1129
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Krametter, D; Niederwieser, G; Berghold, A; Birnbaum, G; Strasser-Fuchs, S; Hartung, HP; Archelos, JJ Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis.
ANN NEUROL. 2001; 49(1): 135-135. Doi: 10.1002%2F1531-8249%28200101%2949%3A1%3C135%3A%3AAID-ANA23%3E3.0.CO%3B2-T
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Previtali, SC; Feltri, ML; Archelos, JJ; Quattrini, A; Wrabetz, L; Hartung, H Role of integrins in the peripheral nervous system.
Prog Neurobiol. 2001; 64(1):35-49 Doi: 10.1016%2FS0301-0082%2800%2900045-9
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Niederwieser, G; Buchinger, W; Bonelli, RM; Berghold, A; Reisecker, F; Archelos, JJ; Koltringer, P Prevalence of thyroid disease in multiple sclerosis
FASEB J 2001 15: A73-A73.
Web of Science

 

2000

Originalarbeit (Zeitschrift)

** Niehaus, A; Shi, J; Grzenkowski, M; Diers-Fenger, M; Archelos, J; Hartung, HP; Toyka, K; Brück, W; Trotter, J Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination.
Ann Neurol. 2000; 48(3):362-371 Doi: 10.1002%2F1531-8249%28200009%2948%3A3%3C362%3A%3AAID-ANA11%3E3.0.CO%3B2-6
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Archelos, JJ; Hartung, HP Demyelinating antibodies in multiple sclerosis - Reply
ANN NEUROL. 2000; 48: 948-948. Doi: 10.1002/1531-8249(200012)48:6<948::AID-ANA20>3.0.CO;2-J
Web of Science FullText FullText_MUG

 

** Schuld, A; Archelos, JJ; Friess, E Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: is the sigma receptor involved?
J Clin Psychopharmacol. 2000; 20(5):579-580 Doi: 10.1097/00004714-200010000-00014 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Archelos, JJ; Hartung, HP Pathogenetic role of autoantibodies in neurological diseases.
TRENDS NEUROSCI. 2000; 23(7): 317-327. Doi: 10.1016/S0166-2236(00)01575-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Archelos, JJ; Storch, MK; Hartung, HP The role of B cells and autoantibodies in multiple sclerosis.
Ann Neurol. 2000; 47(6):694-706 Doi: 10.1002%2F1531-8249%28200006%2947%3A6%3C694%3A%3AAID-ANA2%3E3.0.CO%3B2-W
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Originalarbeit (Zeitschrift)

** Sindou, P; Vallat, JM; Chapon, F; Archelos, JJ; Tabaraud, F; Anani, T; Braund, KG; Maisonobe, T; Hauw, JJ; Vandenberghe, A Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease.
Muscle Nerve. 1999; 22(1):99-104 Doi: 10.1002/(SICI)1097-4598(199901)22:1<99::AID-MUS14>3.0.CO;2-5 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Wewetzer, K; Archelos, JJ; Hartung, HP; Seilheimer, B; Christ, B The monoclonal antibody 23E9 defines a novel developmentally-regulated Schwann cell surface antigen.
Int J Dev Neurosci. 1999; 17(7):715-725 Doi: 10.1016/S0736-5748(99)00046-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Archelos, JJ; Previtali, SC; Hartung, HP The role of integrins in immune-mediated diseases of the nervous system.
Trends Neurosci. 1999; 22(1):30-38 Doi: 10.1016%2FS0166-2236%2898%2901287-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gold, R; Archelos, JJ; Hartung, HP Mechanisms of immune regulation in the peripheral nervous system.
Brain Pathol. 1999; 9(2):343-360 Doi: 10.1111/j.1750-3639.1999.tb00231.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kieseier, BC; Archelos, JJ; Storch, M; Gold, R; Hartung, HP The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy.
Wien Klin Wochenschr. 1999; 111(17):728-737
Web of Science PubMed Google Scholar

 

** Kieseier, BC; Storch, MK; Archelos, JJ; Martino, G; Hartung, HP Effector pathways in immune mediated central nervous system demyelination.
Curr Opin Neurol. 1999; 12(3):323-336 Doi: 10.1097/00019052-199906000-00011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Originalarbeit (Zeitschrift)

** Archelos, JJ; Jung, S; Rinner, W; Lassmann, H; Miyasaka, M; Hartung, HP Role of the leukocyte-adhesion molecule L-selectin in experimental autoimmune encephalomyelitis.
J Neurol Sci. 1998; 159(2):127-134 Doi: 10.1016/S0022-510X(98)00154-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Archelos, JJ; Trotter, J; Previtali, S; Weissbrich, B; Toyka, KV; Hartung, HP Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.
Ann Neurol. 1998; 43(1):15-24 Doi: 10.1002/ana.410430107
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ebers, GC; Rice, G; Lesaux, J; Paty, D; Oger, J; Li DKB, Beall S, Devonshire V, Hashimoto S, Hooge J, Kastrukoff L, Krieger C, Mezei M, Seland P, Vorobeychi G, Morrison W, Nelson J, Freedman MS, Chrisie S, Nelson R, Rabinovitch H, Freedman C, Hartung HP, Rieckmann P, Archelos J, Jung S, Weilbach F, Flachenecke P, Sauer J, Hommes O, Jongen P, Brouwer S, McLeod J, Pollard J, Ng R, Sandberg-Wollheim M, Kallen K, Nilsson P, Ekberg R, Lundgren A, Jadback G, Wikstrom J, Multanen J, Valjakka M, Carton H, Lissoir F, Declerq I, Vieren M, Peeters E, Dubois B, Dekeersmaeker E, Van Herle A, Hughes RAC, Sharrack B, Soudain S, Panelius M, Eralinna J, Soilu-Hanninen M, Murto S, Medaer R, Broeckx J, Vanroose E, Bogaers A, Blumhardt LD, Edwards S, Liu C, Orpe V, Barnes D, Schwartz M, Stoy N, Harraghy C, Bertelsmann F, Uitdehaag B, Nasseri K, Chofflon M, Roth S, Kappos L, Huber S, Bellaiche Y, Senn C, King J, Jubert J, Whitten S, Newsom-Davis JM, Palace J, Lee M, Evangelou N, Pinto A, Cavey A, Sindic CJM, Monteyne P, Verougstraete D, Van Doorn PA, Moll W, Visser L, Willems M, Martina I, Buljevac D, Loman L, Bates D, Pandit D, Irving J, Rhodes B, Riddehough A, Zhao GJ, Wang X, Cheng Y, Ammoury N, Dupont F, Galazka A, Hyde R, Olson M, Pernin MO, Abdul-Ahad AK, Hommes O, Noseworthy J, Borden E, O'Brien P, Wolinsky J Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
LANCET. 1998; 352(9139): 1498-1504. Doi: 10.1016/S0140-6736(98)03334-0
Web of Science PubMed FullText FullText_MUG

 

** Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight R, Hern J, Coleman R, Gerrie L, Cooper G, Moore J, Boringa J, van Oosten B, Ronner H, Schrijver H, Truyen L, Montalban J, Rio J, Tintore M, Jacas C, Marzo E, Lechner-Scott J, Huber S, Lienert C, Brunnschweiler H, Hawkins S, Droogan A, McDonnell G, Duddy M, McKinstry S, Altenkirch H, Baum K, Einhaupl K, Marx P, Poewe W, Walter G, Akman H, Brockmeier B, Scherer P, Zschenderlein R, Schmierer K, Gelderblom H, Hartmann A, Stapf C, Luschow A, Mackert B, Schumacher H, Masuhr F, Hempel T, Zimmermann R, Munch M, Francis D, Heafield M, Al-Memar A, Winer J, Chong M, Brochet B, Gayou A, Auriacombe S, Dousset V, Wiles C, Thomas F, Pickersgill T, Hinds N, Dawson K, Hughes T, Hutchinson M, Murphy R, Redmond J, Webb S, Stoll G, Jander S, Hagemann G, Koller H, Hanemann C, Kolmel H, Reichel D, Petereit K, Thieme A, Khatami A, Neumann M, Amaducci L, Massacesi L, Siracusa G, Amato M, Bartolozzi L, Repice A, Minderhoud J, De Keyser J, Zorgdrager A, Zwanikken C, Poser S, Polak T, Gunther A, Bitsch A, Borner T, Weber F, Wikstrom J, Farkkila M, Majuri H, Sumelahti M, Telakivi T, Fredrikson S, Martin C, Miller D, O'Riordan J, Brex P, Kapoor R, Werring D, Confavreux C, Brunet P, Hannoun D, Brudon F, Moreau T, Blanc S, D'Hooghe M, Jacobs K, Lissoir F, Demonty L, Comi G, Colombo B, Rossi P, Rodegher M, Santuccio G, Martinelli F, Hohlfeld R, Walther E, Goebels N, Dang T, Lindert R, Voltz R, Cartlidge N, Bates D, Moran G, Pandit L, Westwood M, Haller P, Sommer J, Bitter J, Suss F, Mellies J, Mucha P, Lyon-Caen O, Degos JD, Roullet E, Lubetzki C, Creange A, Tourbah A, Pez D, Lecanuet P, Nicolt P, Edan G, Belliard S, De Marco O, Cahagne V, De Burghgraeve V, Brunet I, Fieschi C, Millefiorini E, Gasperini C, Buttinelli C, Frontini M, Howell S, Hadjivassiliou M, Gibson A, Graham A, Harkness K, Lawden M, Clanet M, Wauban E, Azais-Vuillemin C, Lau GKK, Louis C, Panelius M, Ruutiainen J, Eralinna J, Soilu-Hanninen M, Gold R, Hartung HP, Jung S, Bayas A, Flachenecker P, Weilbach F, Archelos J, Kollegger H, Vass K, Asenbaum S, Chatsakos T, Beckmann K, Ghazi M, Wagner K, Miltenburger C, McFarland H, Petkau J, Sabouraud O, Toyka K Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
LANCET. 1998; 352(9139): 1491-1497. Doi: 10.1016/S0140-6736(98)10039-9
Web of Science PubMed FullText FullText_MUG

 

** Previtali, SC; Archelos, JJ; Hartung, HP Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome.
Ann Neurol. 1998; 44(4):611-621 Doi: 10.1002/ana.410440406
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Originalarbeit (Zeitschrift)

** Archelos, JJ; Fortwängler, T; Hartung, HP Attenuation of experimental autoimmune neuritis in the Lewis rat by treatment with an antibody to L-selectin.
Neurosci Lett. 1997; 235(1-2):9-12 Doi: 10.1016%2FS0304-3940%2897%2900692-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Previtali, SC; Archelos, JJ; Hartung, HP Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha.
Am J Pathol. 1997; 151(5):1425-1435 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Übersichtsarbeit

** Archelos, JJ; Hartung, HP The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications.
Mol Med Today. 1997; 3(7):310-321 Doi: 10.1016/S1357-4310(97)01066-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Vallat, JM; Sindou, P; Chapan, F; Archelos, JJ; Tabaraud, F; Braund, KG; Maisonobe, T; Haun, JJ; Vandenberghe, A Ultrastructural quantification of PO immunoreactivity on biopsied sural nerves from patients with Charcot-Marie-Tooth disease type 1B
ANN NEUROL 1997 42: M96-M96.
Web of Science

 

1996

Originalarbeit (Zeitschrift)

** Morrissey, SP; Deichmann, R; Syha, J; Simonis, C; Zettl, U; Archelos, JJ; Jung, S; Stodal, H; Lassmann, H; Toyka, KV; Haase, A; Hartung, HP Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies.
J Neuroimmunol. 1996; 69(1-2):85-93 Doi: 10.1016/0165-5728(96)00064-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Originalarbeit (Zeitschrift)

** Hartung, HP; Reiners, K; Archelos, JJ; Michels, M; Seeldrayers, P; Heidenreich, F; Pflughaupt, KW; Toyka, KV Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging.
ANN NEUROL. 1995; 38(2): 186-193. Doi: 10.1002/ana.410380210
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Archelos, JJ; Toyka, KV; Hartung, HP B cell responses to the PNS protein P0 in experimental autoimmune neuritis.
J Neurol Sci. 1995; 128(1):111-111 Doi: 10.1016/0022-510X(94)00246-K
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Hartung, HP; Archelos, JJ; Zielasek, J; Gold, R; Koltzenburg, M; Reiners, KH; Toyka, KV Circulating adhesion molecules and inflammatory mediators in demyelination: a review.
Neurology. 1995; 45(6 Suppl 6):S22-S32 Doi: 10.1212/WNL.45.6_Suppl_6.S22
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Originalarbeit (Zeitschrift)

** ARCHELOS, JJ; MAURER, M; JUNG, S; MIYASAKA, M; TAMATANI, T; TOYKA, KV; HARTUNG, HP Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
Lab Invest. 1994; 70(5):667-675
Web of Science PubMed Google Scholar

 

Übersichtsarbeit

** Hartung, HP; Gold, R; Zielasek, J; Archelos, JJ; Toyka, KV Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)
NERVENARZT. 1994; 65(12): 807-818.
Web of Science PubMed

 

1993

Originalarbeit (Zeitschrift)

** ARCHELOS, JJ; JUNG, S; MAURER, M; SCHMIED, M; LASSMANN, H; TAMATANI, T; MIYASAKA, M; TOYKA, KV; HARTUNG, HP Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Ann Neurol. 1993; 34(2):145-154 Doi: 10.1002/ana.410340209
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** ARCHELOS, JJ; MAURER, M; JUNG, S; TOYKA, KV; HARTUNG, HP Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1.
Brain. 1993; 116 ( Pt 5)(11):1043-1058 Doi: 10.1093/brain/116.5.1043
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** ARCHELOS, JJ; ROGGENBUCK, K; SCHNEIDERSCHAULIES, J; LININGTON, C; TOYKA, KV; HARTUNG, HP Production and characterization of monoclonal antibodies to the extracellular domain of P0.
J Neurosci Res. 1993; 35(1):46-53 Doi: 10.1002/jnr.490350107
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** ARCHELOS, JJ; ROGGENBUCK, K; SCHNEIDERSCHAULIES, J; TOYKA, KV; HARTUNG, HP Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.
J Neurol Sci. 1993; 117(1-2):197-205 Doi: 10.1016/0022-510X(93)90174-W
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** HARTUNG, HP; MICHELS, M; REINERS, K; SEELDRAYERS, P; ARCHELOS, JJ; TOYKA, KV Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis.
Neurology. 1993; 43(11):2331-2335 Doi: 10.1212/WNL.43.11.2331
Web of Science PubMed FullText FullText_MUG

 

** STOLL, G; JANDER, S; JUNG, S; ARCHELOS, J; TAMATANI, T; MIYASAKA, M; TOYKA, KV; HARTUNG, HP Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system.
Lab Invest. 1993; 68(6):637-644
Web of Science PubMed Google Scholar

 

** ZIELASEK, J; ARCHELOS, JJ; TOYKA, KV; HARTUNG, HP Expression of intercellular adhesion molecule-1 on rat microglial cells.
Neurosci Lett. 1993; 153(2):136-139 Doi: 10.1016/0304-3940(93)90306-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** HARTUNG, HP; ARCHELOS, JJ; JUNG, S; MIYASAKA, M; TOYKA, KV INHIBITION OF EXPERIMENTAL AUTOIMMUNE NEURITIS BY MONOCLONAL-ANTIBODIES TO ICAM-1 AND LFA-1
NEUROLOGY. 1993; 43(4): A395-A395.
Web of Science

 

1992

Übersichtsarbeit

** HARTUNG, HP; JUNG, SF; STOLL, G; ZIELASEK, J; SCHMIDT, B; ARCHELOS, JJ; TOYKA, KV Inflammatory mediators in demyelinating disorders of the CNS and PNS.
J Neuroimmunol. 1992; 40(2-3):197-210 Doi: 10.1016/0165-5728(92)90134-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Originalarbeit (Zeitschrift)

** SCHNEIDERSCHAULIES, J; KIRCHHOFF, F; ARCHELOS, J; SCHACHNER, M Down-regulation of myelin-associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth.
Neuron. 1991; 7(6):995-1005 Doi: 10.1016/0896-6273(91)90344-Y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1985

Abstract (Zeitschrift)

** LANG, RE; RUSKOAHO, H; THOLKEN, H; ARCHELOS, J; GANTEN, D; UNGER, T REGULATION OF RELEASE OF ATRIAL NATRIURETIC HORMONES
J HYPERTENSION. 1985; 3: S551-S551.
Web of Science

 

1984

Originalarbeit (Zeitschrift)

** XIANG, JZ; ARCHELOS, J; LANG, RE Enkephalins in the heart.
Clin Exp Hypertens A. 1984; 6(10-11):1883-1888 Doi: 10.3109/10641968409046097
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** GANTEN, D; LANG, RE; ARCHELOS, J; UNGER, T Peptidergic systems: effects on blood vessels.
J Cardiovasc Pharmacol. 1984; 6 Suppl 4(10-11):S598-S607 Doi: 10.1097/00005344-198406004-00006
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** LANG, RE; PETTY, M; ARCHELOS, J; GANTEN, D; HERMANN, K; UNGER, T; XIANG, J DYNORPHINS ARE NEUROTRANSMITTERS IN CARDIAC SYMPATHETIC-NERVES
HYPERTENSION. 1984; 6(5): 787-787.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum